Invesco BulletShares 2028 Corporate Bond (BSCS)
BSCS price chart
BSCS fund facts
Returns and risk
Cost: expense ratio
On $10,000 invested that is about $10 a year in fund costs, taken out of the fund's assets.
Income: distributions
BSCS top holdings
| # | Holding | Weight |
|---|---|---|
| 1 | Invesco Private Prime Fund | 4.89% |
| 2 | Invesco Private Government Fund | 1.85% |
| 3 | CVS Health Corp. | 1.14% |
| 4 | Amgen Inc. | 0.87% |
| 5 | Cigna Group (The) | 0.87% |
| 6 | AerCap Ireland Capital DAC / AerCap Global Aviation Trust | 0.83% |
| 7 | Salesforce, Inc. | 0.80% |
| 8 | NVIDIA Corp. | 0.80% |
| 9 | RTX Corp. | 0.68% |
| 10 | Sprint Capital Corp. | 0.59% |
Similar Bond ETFs
GVI iShares Intermediate Governmen...0.20% fee · +0.9% 1y CGHM Capital Group Municipal High-I...0.34% fee · +2.5% 1y CPLB NYLI MacKay Core Plus Bond0.30% fee · +0.9% 1y EAGG iShares ESG U.S. Aggregate Bon...0.10% fee · +0.2% 1y NXUS Nuveen International Aggregate...0.08% fee · +0.2% 1y MMIN IQ MacKay Municipal Insured0.30% fee · +1.3% 1y All bond ETFs →BSCS: frequently asked questions
What is BSCS?
BSCS is the Invesco BulletShares 2028 Corporate Bond ETF, issued by Invesco, listed on NASDAQ. By our rules it is classed as "Bond". Its latest SEC filing lists 485 holdings.
What is the expense ratio of BSCS?
BSCS charges 0.10% a year, according to its prospectus filed with the SEC on 18 Dec 2025. On $10,000 that is about $10 a year in fund costs.
Does BSCS pay dividends?
Yes. BSCS paid 0.90 per share over the last 12 months, monthly, a trailing yield of 4.44% on today's price. The latest ex-dividend date was 19 Oct 2026.
What does BSCS hold?
The largest holdings in the latest SEC filing are Invesco Private Prime Fund (4.9%), Invesco Private Government Fund (1.9%), CVS Health Corp. (1.1%). The top 10 together make up 13.3% of the fund.
How has BSCS performed?
Total return including distributions to 6 Nov 2026: 1 year +2.7%, 3 years +6.0% a year, 5 years +1.4% a year. Past performance does not guarantee future results.
Where the numbers come from
StocksXray is for education only and is not financial advice or a recommendation to buy or sell anything. Past performance does not guarantee future results; funds can lose value.